MaxCyte, Inc.
MaxCyte, Inc. (MXCT) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
mxct · stock forecast · 6 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 6 Wall Street analysts in the past 3 months
Buy
6 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$6.00
Consensus
$6.00
+406.3% upside
Low
$6.00
Median: $6 · Last Close: $1.19
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.24 | ↑ 5.00% |
1-day model range: $1.23–$1.26. Peak: $1.26 (+5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -50.0% |
| 2028 | $0 | -62.5% |
| 2029 | $0 | -67.2% |
| 2030 | $0 | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MXCT · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-25 | Craig-Hallum | Maintains | Buy→Buy |
| 2025-08-11 | BTIG | Downgrade ↓ | Buy→Neutral |
| 2025-08-07 | William Blair | Downgrade ↓ | Outperform→Market Perform |
| 2025-03-12 | Stifel | Maintains | Buy→Buy |
| 2024-04-23 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2024-03-13 | BTIG | Maintains | Buy→Buy |
| 2024-03-13 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2023-10-05 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2023-03-28 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2022-08-15 | BTIG | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on MaxCyte, Inc. (MXCT) stock. Of the recent 15 rating actions, 0 were upgrades and 2 were downgrades. 6 analysts currently cover MXCT.
Analyst Recommendation Trends
MXCT analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$35M
↓ 6.5% YoY
Revenue Next Year
$31M
↓ 11.5% YoY
EPS This Year
$-0.39
EPS Next Year
$-0.26
↓ 33.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast MXCT EPS of $-0.39 for the current fiscal year, based on estimates from 3 analysts. The MXCT revenue forecast is $35M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The MXCT stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MXCT price target is $6.00 (+406.3% upside), with an analyst consensus of Buy.
The MXCT short-term stock prediction for tomorrow is $1.24 (+5.00%). The MXCT stock price prediction for 2027 estimates an average of $1. The MXCT stock prediction for 2030 projects a range of $0–$0.
MaxCyte, Inc. trades on NASDAQ under the ticker MXCT. The MXCT stock outlook for 2027 is broadly positive, supported by a Buy consensus among 67% of covering analysts.
Frequently asked questions
MXCT forecast · 8 questionsAccording to 6 Wall Street analysts, the average 12-month MXCT price target is $6.00, with a high forecast of $6.00 and a low of $6.00. The median price target is shown in the chart above when available. This implies +406.3% potential upside from the current price of $1.19.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.